When was RedDress founded?

RedDress was founded in 2009 and raised its 1st funding round 14 years after it was founded.

Where is RedDress located?

RedDress is headquartered in Ponte Vedra Beach, United States. It is registered at 822 A1A N STE 310,PONTE VEDRA,FL,32082,0.

How many employees does RedDress have?

As of Apr 30, 2026, the latest employee count at RedDress is 31.

Is RedDress a funded company?

RedDress is a funded company, having raised a total of $***** in its 1st and only funding round, a Series D round on May 24, 2023.

When was the latest funding round of RedDress?

RedDress' latest funding was a $***** Series D round on May 24, 2023, with participation from 3 investors. Its primary sector is Wound Care. In United States, the Wound Care sector has seen $17.9M in funding in 2026 to date.

Where does RedDress rank among its competitors?

RedDress ranks 19th amongst 118 active competitors, of which 15 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Kane Biotech, which secured $840K in May, 2026.

Who are the top competitors of RedDress?

RedDress' top competitors include Imbed Biosciences, Kane Biotech and Cresilon. Among them, Kane Biotech secured the most recent funding round in May, 2026.

RedDress - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of dressing solution for wound care. The product ActiGraft dressing contains the fibrin matrix derived from the patient's blood clot that helps as a protective covering and supports wound healing processes.

Website: reddressmedical.com
Social
Email ID: *****@reddressmedical.com
Phone Number: +1 **********
Registered Address: 822 A1A N STE 310,PONTE VEDRA,FL,32082,0

Key Metrics

Founded Year

2009

Location

Ponte Vedra Beach, United States

Stage

Series D

Total Funding

$43M in 1 round

Latest Funding Round

Series D, May 24, 2023, $*****

Investors

HCS Capital Partners & 4 more

Ranked

19^th among 118 active competitors

Employee Count

31 as on Apr 30, 2026

Similar Companies

Imbed Biosciences & 140 more

View RedDress' full profile

RedDress is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
REDDRESS USA INC. CIN: 32080382842 , United States, Active		-	-	-

RedDress has raised a total funding of $43M over 1 round. Its latest funding round was a Series D round on May 24, 2023 for $*****. 3 investors participated in its latest round. RedDress has 5 institutional investors.

Here is the list of recent funding rounds of RedDress:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 24, 2023	5641304	Series D	9868039	1117769	5693211	8860022

Access funding benchmarks and valuations. Sign up today!

View details of RedDress's funding rounds and investors

RedDress' employee count trend

RedDress has 31 employees as of Apr 26. Here is RedDress's employee count trend over the years:

Uncover RedDress' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of RedDress include Imbed Biosciences, Kane Biotech and Cresilon. Here is the list of Top 10 competitors of RedDress, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Imbed Biosciences 2010, Madison (United States), Series C	Provider of nanotech-based wound care products	$34.3M	MassChallenge, WISC Partners & 7 others	68/100
2nd	Kane Biotech 2001, Winnipeg (Canada), Public	Developer of therapeutic solutions to prevent and remove biofilms	-	MTEC, National Research Council Canada & 2 others	58/100
3rd	Cresilon 2010, New York City (United States), Series B	Developer of hemostatic products for wound care	$118M	Paulson Investment, IMEX VP Investment Group ... & 6 others	58/100
4th	NuVision 2015, Nottingham (United Kingdom), Public	Developer of an ophthalmic therapies for ocular surface disease	$13.4M	Mercia, Nottingham Technology Ventures & 35 others	57/100
5th	Alafair Biosciences 2011, Austin (United States), Series B	Biomaterials and biomedical devices that enhance internal wound healing	$13.7M	ATP, Austin Technology Incubator & 4 others	56/100
6th	Lohmann & Rauscher 1998, Rengsdorf (Germany), Funding Raised	Dressing materials and medical devices	-	Austria Wirtschaftsservice, Gov.cz	47/100
7th	Regenics 2005, Oslo (Norway), Public	Developer of marine-ingredient based wound care products	-	-	47/100
8th	Shanghai Haohai Biological Technology 2007, Jinzhong (China), Funding Raised	Manufacturer of absorbable biomedical materials.	-	DM Capital	45/100
9th	Beeken Biomedical 2011, Stoughton (United States), Public	Bleeding control solutions for surgical, trauma, and public safety applications	$8.83M	-	43/100
10th	Symatese 2001, Chaponost (France), Funding Raised	Developer of hemostatic material and bone-subsitutes	-	Picardie Investissement, Credit Mutuel Equity	41/100
19th	RedDress 2009, Ponte Vedra Beach (United States), Series D	Provider of dressing solution for wound care	$43M	HCS Capital Partners, Cashline Investment Holding ... & 3 others	35/100